THÉRAPIE COMBINÉE POUR LE TRAITEMENT DU CANCER
- 专利权人:
- Genzyme Corporation
- 发明人:
- 申请号:
- EP18182899.7
- 公开号:
- EP3406141A1
- 申请日:
- 2011.03.08
- 申请国别(地区):
- EP
- 年份:
- 2018
- 代理人:
- 摘要:
- The invention provides compositions and methods for treating cancer. Specifically, the invention relates to administering a Transforming Growth Factor beta (TGFβ) antagonist in combination with capecitabine and ixabepilone to treat cancer.
- 来源网站:
- 中国工程科技知识中心